Cadila Healthcare spurts as its Topical manufacturing facility successfully completes USFDA inspection

07 Apr 2017 Evaluate

Cadila Healthcare is currently trading at Rs. 456.00, up by 7.90 points or 1.76% from its previous closing of Rs. 448.10 on the BSE.

The scrip opened at Rs. 448.10 and has touched a high and low of Rs. 466.10 and Rs. 447.50 respectively. So far 937076 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 466.10 on 07-April-2017 and a 52 week low of Rs. 305.00 on 12-Apr-2016.

Last one week high and low of the scrip stood at Rs. 466.10 and Rs. 442.00 respectively. The current market cap of the company is Rs. 46866.94 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.18% and 8.03% respectively.

Cadila Healthcare’s Topical manufacturing located at Changodar was successfully inspected by US Food & Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no observation (483) is issued. The company has filed 17 products with the USFDA from this manufacturing facility.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×